These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12702510)

  • 21. Btk plays a crucial role in the amplification of Fc epsilonRI-mediated mast cell activation by kit.
    Iwaki S; Tkaczyk C; Satterthwaite AB; Halcomb K; Beaven MA; Metcalfe DD; Gilfillan AM
    J Biol Chem; 2005 Dec; 280(48):40261-70. PubMed ID: 16176929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells.
    Tanaka S; Takasu Y; Mikura S; Satoh N; Ichikawa A
    J Exp Med; 2002 Jul; 196(2):229-35. PubMed ID: 12119347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Balanced interactions between Lyn, the p85alpha regulatory subunit of class I(A) phosphatidylinositol-3-kinase, and SHIP are essential for mast cell growth and maturation.
    Ma P; Vemula S; Munugalavadla V; Chen J; Sims E; Borneo J; Kondo T; Ramdas B; Mali RS; Li S; Hashino E; Takemoto C; Kapur R
    Mol Cell Biol; 2011 Oct; 31(19):4052-62. PubMed ID: 21791602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells.
    Gustin SE; Thien CB; Langdon WY
    J Immunol; 2006 Nov; 177(9):5980-9. PubMed ID: 17056522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lyn is essential for fcgamma receptor III-mediated systemic anaphylaxis but not for the Arthus reaction.
    Yuasa T; Ono M; Watanabe T; Takai T
    J Exp Med; 2001 Mar; 193(5):563-72. PubMed ID: 11238587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.
    Kawakami Y; Kitaura J; Satterthwaite AB; Kato RM; Asai K; Hartman SE; Maeda-Yamamoto M; Lowell CA; Rawlings DJ; Witte ON; Kawakami T
    J Immunol; 2000 Aug; 165(3):1210-9. PubMed ID: 10903718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulus strength determines the BTK-dependence of the SHIP1-deficient phenotype in IgE/antigen-triggered mast cells.
    Zorn CN; Simonowski A; Huber M
    Sci Rep; 2018 Oct; 8(1):15467. PubMed ID: 30341350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous induction of HSP70 expression, and degranulation, in IgE/Ag-stimulated or extracellular HSP70-stimulated mast cells.
    Li X; Kanegasaki S; Jin F; Deng Y; Kim JR; Chang HW; Tsuchiya T
    Allergy; 2018 Feb; 73(2):361-368. PubMed ID: 28857181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spiraeoside inhibits mast cells activation and IgE-mediated allergic responses by suppressing phospholipase C-γ-mediated signaling.
    Kim JK; Seo YK; Park S; Park SA; Lim S; Lee S; Kwon O; Seo JK; Choi UK; Ryu SH; Suh PG
    Biochem Cell Biol; 2015 Jun; 93(3):227-35. PubMed ID: 25781488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.
    Xiao W; Nishimoto H; Hong H; Kitaura J; Nunomura S; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Ra C; Kawakami T
    J Immunol; 2005 Nov; 175(10):6885-92. PubMed ID: 16272347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Akt cross-links IL-4 priming, stem cell factor signaling, and IgE-dependent activation in mature human mast cells.
    Feuser K; Feilhauer K; Staib L; Bischoff SC; Lorentz A
    Mol Immunol; 2011 Jan; 48(4):546-52. PubMed ID: 21106245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin potentiates FcepsilonRI-mediated signaling in mouse bone marrow-derived mast cells.
    Kettner A; Di Matteo M; Santoni A
    Mol Immunol; 2010 Feb; 47(5):1039-46. PubMed ID: 20004975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
    Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
    Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The quantity and duration of FcRgamma signals determine mast cell degranulation and survival.
    Yamasaki S; Ishikawa E; Kohno M; Saito T
    Blood; 2004 Apr; 103(8):3093-101. PubMed ID: 15070690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase-1, and hematopoietic prostaglandin D2 synthase and increased IgE-dependent prostaglandin D2 generation in immature mouse mast cells.
    Murakami M; Matsumoto R; Urade Y; Austen KF; Arm JP
    J Biol Chem; 1995 Feb; 270(7):3239-46. PubMed ID: 7531701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of genes linked to FcepsilonRI Signaling and to cytokine and chemokine production in Lyn-deficient mast cells.
    Hernandez-Hansen V; Bard JD; Tarleton CA; Wilder JA; Lowell CA; Wilson BS; Oliver JM
    J Immunol; 2005 Dec; 175(12):7880-8. PubMed ID: 16339523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WZ3146 inhibits mast cell Lyn and Fyn to reduce IgE-mediated allergic responses in vitro and in vivo.
    Park YH; Kim DK; Kim HS; Lee D; Lee MB; Min KY; Jo MG; Lee JE; Kim YM; Choi WS
    Toxicol Appl Pharmacol; 2019 Nov; 383():114763. PubMed ID: 31526816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired tyrosine phosphorylation and Ca2+ mobilization, but not degranulation, in lyn-deficient bone marrow-derived mast cells.
    Nishizumi H; Yamamoto T
    J Immunol; 1997 Mar; 158(5):2350-5. PubMed ID: 9036984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells.
    Ishizuka T; Chayama K; Takeda K; Hamelmann E; Terada N; Keller GM; Johnson GL; Gelfand EW
    J Immunol; 1999 Feb; 162(4):2087-94. PubMed ID: 9973482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential use of BTK and PLC in FcεRI- and KIT-mediated mast cell activation: A marginal role of BTK upon KIT activation.
    Simonowski A; Wilhelm T; Habib P; Zorn CN; Huber M
    Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118622. PubMed ID: 31837347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.